Phase II trial of cabiralizumab with nivolumab in advanced pancreatic cancer misses primary endpoint Feb. 19, 2020
Diasome reports promising outcomes from phase II trial of HDV added to insulin in type 1 diabetes Feb. 19, 2020
Complete response recorded in first patient treated with optimized MB-106 in phase I/II study Feb. 19, 2020
CD229-specific CAR T cells with strong activity against multiple myeloma in vitro and in vivo Feb. 19, 2020
Combination of new CD28- and CD3-based bispecific antibodies shows high antitumor activity Feb. 19, 2020
RSS